Eye drop trial aims to halt worsening vision in kids
Disease control
Recruiting now
This study is testing whether low-dose atropine eye drops can slow down the progression of nearsightedness (myopia) in children and teenagers. It will involve about 234 participants aged 3 to 18 across several European countries. The trial will compare two strengths of atropine d…
Phase: PHASE3 • Sponsor: Ocus Innovation Ireland Limited • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC